Drug Type Small molecule drug |
Synonyms |
Mechanism KLKB1 inhibitors(Plasma kallikrein inhibitors), Plasmin inhibitors, Serine protease inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H14N2O5S3 |
InChIKeyMCPAUXMAIOICMC-UHFFFAOYSA-N |
CAS Registry217099-44-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Blood Coagulation Disorders | Phase 2 | - | - | |
Reperfusion Injury | Phase 2 | - | - |